Dr Reddys
- All
- News
- Videos
-
All About Andhra Pradesh's Ex Chief Minister Jagan Mohan Reddy, Involved In Feud With Sister
- Wednesday October 30, 2024
- India News | Edited by NDTV News Desk
Jagan Reddy is the son of the late Dr YS Rajasekhara Reddy (YSR), two-time former Chief Minister of Andhra Pradesh.
- www.ndtv.com
-
Andhra Chief Minister Unveils World's Largest Statue Of BR Ambedkar
- Saturday January 20, 2024
- India News | Asian News International
In a significant move towards promoting inclusivity and honouring the contributions of BR Ambedkar, Andhra Pradesh Chief Minister YS Jagan Mohan Reddy on Friday unveiled the statue of Dr BR Ambedkar in Vijayawada.
- www.ndtv.com
-
Sensex, Nifty End At New All-Time Highs, Sustain Momentum For 6th Day
- Tuesday November 29, 2022
- Business | Press Trust of India
Among the Sensex pack, Hindustan Unilever, Sun Pharma, Nestle, Dr Reddy's, Tata Steel, ICICI Bank, Titan and HCL Technologies were the major winners.
- www.ndtv.com/business
-
Antitrust Litigation Filed Against Dr Reddy's Laboratories In US
- Tuesday November 22, 2022
- Business | Press Trust of India
Dr Reddy's Laboratories Ltd on Tuesday said it is among several generic pharmaceutical companies, including Celgene and Bristol Myers Squibb, against which an antitrust litigation has been filed in the US.
- www.ndtv.com/business
-
Dr Reddy's To Earmark Rs 1,500 Crore Capex For Biosimilars, Injectables
- Sunday November 6, 2022
- Business | Press Trust of India
Dr Reddy's Laboratories has earmarked a capex of around Rs 1,500 crore for FY23 with major part of it slated to go into building capacities for its biosimilar and injectable businesses.
- www.ndtv.com/business
-
Dr Reddy's, Cipla, Aurobindo Units Recall Products From US Market
- Sunday October 23, 2022
- Business | Press Trust of India
Leading drug firms Dr Reddy's Laboratories, Cipla and Aurobindo Pharma are recalling different products in the US market for various issues, according to the US Food and Drug Administration.
- www.ndtv.com/business
-
Supreme Court Rejects Pleas Challenging 'Proposer' Requirement In President Poll
- Wednesday June 29, 2022
- India News | Press Trust of India
A vacation bench comprising justices Surya Kant and JB Pardiwala was hearing separate pleas filed by Delhi resident Bam Bam Maharaj Nowhattia and Dr Mandati Thirupathi Reddy, a native of Prakasam district in Andhra Pradesh, on the issue.
- www.ndtv.com
-
Dr Reddy's Plans 'Business Continuity' In Russia
- Wednesday March 9, 2022
- Business | Reuters
Indian pharmaceutical major Dr. Reddy's Laboratories Ltd said on Wednesday it was focused on employee safety and business continuity in and around Russia, despite many Western companies pulling out from Russia in recent days.
- www.ndtv.com/business
-
Dr Reddy's Laboratories Gets FDA Approval, Launches Drug In US Market
- Wednesday February 9, 2022
- India News | Press Trust of India
Dr Reddy's Laboratories on Wednesday said it has launched a vasopressin injection, which is used to control frequent urination, increased thirst, and loss of water caused by diabetes, in the American market.
- www.ndtv.com
-
Proposal For Sputnik Light As Covid Booster Submitted To Drug Regulator
- Monday February 7, 2022
- India News | Press Trust of India
Drug major Dr Reddy's Laboratories has submitted a proposal to the Drugs Controller General of India (DCGI) to register Sputnik Light vaccine as a booster dose against COVID-19, a top company official has said.
- www.ndtv.com
-
Trying To Bring Vaccine For 12-18 Age Group To India: Dr Reddy's
- Friday January 28, 2022
- India News | Press Trust of India
Dr Reddy's Laboratories on Friday said it is in discussions with the Indian drug regulator to bring Russia's Sputnik M, a COVID-19 vaccine for the 12 to18-year-old category, to India.
- www.ndtv.com
-
Sensex Tanks Over 700 Points, Nifty Trades Below 17,550; Tech Mahindra, Bajaj Finserv, Dr Reddy's Among Top Drags
- Friday January 21, 2022
- Business | Edited by Prashun Talukdar
The Indian equity benchmarks continued to plunge for the fourth straight session on Friday amid weak global cues.
- www.ndtv.com/business
-
All About Andhra Pradesh's Ex Chief Minister Jagan Mohan Reddy, Involved In Feud With Sister
- Wednesday October 30, 2024
- India News | Edited by NDTV News Desk
Jagan Reddy is the son of the late Dr YS Rajasekhara Reddy (YSR), two-time former Chief Minister of Andhra Pradesh.
- www.ndtv.com
-
Andhra Chief Minister Unveils World's Largest Statue Of BR Ambedkar
- Saturday January 20, 2024
- India News | Asian News International
In a significant move towards promoting inclusivity and honouring the contributions of BR Ambedkar, Andhra Pradesh Chief Minister YS Jagan Mohan Reddy on Friday unveiled the statue of Dr BR Ambedkar in Vijayawada.
- www.ndtv.com
-
Sensex, Nifty End At New All-Time Highs, Sustain Momentum For 6th Day
- Tuesday November 29, 2022
- Business | Press Trust of India
Among the Sensex pack, Hindustan Unilever, Sun Pharma, Nestle, Dr Reddy's, Tata Steel, ICICI Bank, Titan and HCL Technologies were the major winners.
- www.ndtv.com/business
-
Antitrust Litigation Filed Against Dr Reddy's Laboratories In US
- Tuesday November 22, 2022
- Business | Press Trust of India
Dr Reddy's Laboratories Ltd on Tuesday said it is among several generic pharmaceutical companies, including Celgene and Bristol Myers Squibb, against which an antitrust litigation has been filed in the US.
- www.ndtv.com/business
-
Dr Reddy's To Earmark Rs 1,500 Crore Capex For Biosimilars, Injectables
- Sunday November 6, 2022
- Business | Press Trust of India
Dr Reddy's Laboratories has earmarked a capex of around Rs 1,500 crore for FY23 with major part of it slated to go into building capacities for its biosimilar and injectable businesses.
- www.ndtv.com/business
-
Dr Reddy's, Cipla, Aurobindo Units Recall Products From US Market
- Sunday October 23, 2022
- Business | Press Trust of India
Leading drug firms Dr Reddy's Laboratories, Cipla and Aurobindo Pharma are recalling different products in the US market for various issues, according to the US Food and Drug Administration.
- www.ndtv.com/business
-
Supreme Court Rejects Pleas Challenging 'Proposer' Requirement In President Poll
- Wednesday June 29, 2022
- India News | Press Trust of India
A vacation bench comprising justices Surya Kant and JB Pardiwala was hearing separate pleas filed by Delhi resident Bam Bam Maharaj Nowhattia and Dr Mandati Thirupathi Reddy, a native of Prakasam district in Andhra Pradesh, on the issue.
- www.ndtv.com
-
Dr Reddy's Plans 'Business Continuity' In Russia
- Wednesday March 9, 2022
- Business | Reuters
Indian pharmaceutical major Dr. Reddy's Laboratories Ltd said on Wednesday it was focused on employee safety and business continuity in and around Russia, despite many Western companies pulling out from Russia in recent days.
- www.ndtv.com/business
-
Dr Reddy's Laboratories Gets FDA Approval, Launches Drug In US Market
- Wednesday February 9, 2022
- India News | Press Trust of India
Dr Reddy's Laboratories on Wednesday said it has launched a vasopressin injection, which is used to control frequent urination, increased thirst, and loss of water caused by diabetes, in the American market.
- www.ndtv.com
-
Proposal For Sputnik Light As Covid Booster Submitted To Drug Regulator
- Monday February 7, 2022
- India News | Press Trust of India
Drug major Dr Reddy's Laboratories has submitted a proposal to the Drugs Controller General of India (DCGI) to register Sputnik Light vaccine as a booster dose against COVID-19, a top company official has said.
- www.ndtv.com
-
Trying To Bring Vaccine For 12-18 Age Group To India: Dr Reddy's
- Friday January 28, 2022
- India News | Press Trust of India
Dr Reddy's Laboratories on Friday said it is in discussions with the Indian drug regulator to bring Russia's Sputnik M, a COVID-19 vaccine for the 12 to18-year-old category, to India.
- www.ndtv.com
-
Sensex Tanks Over 700 Points, Nifty Trades Below 17,550; Tech Mahindra, Bajaj Finserv, Dr Reddy's Among Top Drags
- Friday January 21, 2022
- Business | Edited by Prashun Talukdar
The Indian equity benchmarks continued to plunge for the fourth straight session on Friday amid weak global cues.
- www.ndtv.com/business